domain	dictionary	value	description
adverseevents	adverseevents_severity	acute	
adverseevents	adverseevents_severity	all grades	
adverseevents	adverseevents_severity	below serious	As reported by ClinicalTrials.gov, """"other"""" grade
adverseevents	adverseevents_severity	extreme	
adverseevents	adverseevents_severity	grade 1	
adverseevents	adverseevents_severity	grade 1-2	
adverseevents	adverseevents_severity	grade 1-3	
adverseevents	adverseevents_severity	grade 1-4	
adverseevents	adverseevents_severity	grade 2	
adverseevents	adverseevents_severity	grade 2-3	
adverseevents	adverseevents_severity	grade 2-4	
adverseevents	adverseevents_severity	grade 2-5	
adverseevents	adverseevents_severity	grade 3	
adverseevents	adverseevents_severity	grade 3-4	
adverseevents	adverseevents_severity	grade 3-5	
adverseevents	adverseevents_severity	grade 4	
adverseevents	adverseevents_severity	grade 4-5	
adverseevents	adverseevents_severity	grade 5	Fatal adverse event
adverseevents	adverseevents_severity	light	
adverseevents	adverseevents_severity	major	
adverseevents	adverseevents_severity	marked	
adverseevents	adverseevents_severity	mild	
adverseevents	adverseevents_severity	moderate	
adverseevents	adverseevents_severity	non-serious	
adverseevents	adverseevents_severity	serious	
adverseevents	adverseevents_severity	severe	
adverseevents	adverseevents_severity	significant	
adverseevents	adverseevents_severity	slight	
adverseevents	adverseevents_severity	uncertain	
adverseevents	adverseevents_type	discontinuation	Adverse event that lead to treatment discontinuation
adverseevents	adverseevents_type	dose interruption	Adverse event that lead to dose interruption
adverseevents	adverseevents_type	dose reduction	Adverse event that lead to dose reduction
adverseevents	ae_is_dlt	TRUE	Adverse event is reported as dose-limiting toxicity for the drug
ddi	ddi_clin_evidence	biomarker study	Clinically administered drug has effect on target-related biomarker
ddi	ddi_clin_evidence	co-administration study	DDI was measured by co-administration with probe substrate
ddi	ddi_clin_evidence	expression study	Protein expression measurement in tissues from patients who administered the drug
ddi	ddi_clin_evidence	pharmacogenomic study	DDI was measured by studying effect of target genotype variation on the drug PK parameters
ddi	ddi_clin_evidence	QT study	Effect of the drug on QT interval was measured in clinics
ddi	ddi_clin_support	likely	No experiments were conducted, but PK modeling suggests clinical relevance of interactions
ddi	ddi_clin_support	no	Clinical experiments were conducted and no evidence supporting the interaction was found
ddi	ddi_clin_support	unknown	Clinical experiments are ongoing, no results were published
ddi	ddi_clin_support	unlikely	No experiments were conducted, but PK modeling suggests lack of clinical relevance
ddi	ddi_clin_support	weak	Clinical experiments were conducted and no weak evidence supporting the interaction was found (probe drugs exposure increase <1.5x or decrease to >0.67x)
ddi	ddi_clin_support	yes	Clinical experiments were conducted and found that interaction has clinical relevance
ddi	ddi_magnitude	no	Drug doesn't interact with a target
ddi	ddi_magnitude	strong	Drug strongly interacts with a target (major substrate, strong/clinically relevant inhibitor or inducer)
ddi	ddi_magnitude	weak	Drug weakly interacts with a target
ddi	ddi_magnitude	yes	Drug interacts with a targets
ddi	ddi_relation	activator	Drug activates target
ddi	ddi_relation	binder	Drug binds to a target, but no information about its effect is available
ddi	ddi_relation	inducer	Drug induces target expression and activity
ddi	ddi_relation	inhibitor	Drug inhibits target
ddi	ddi_relation	substrate	Drug is a substrate of a target
ddi	ddi_relation	suppressor	Drug supresses expression of a target
ddi	ddi_type	Activation	Activation (%) at a given concentration (uM)
ddi	ddi_type	EC50	EC50 (uM)
ddi	ddi_type	IC50	IC50 (uM)
ddi	ddi_type	Inhibition	Inhibition (%) at a given concentration (uM)
ddi	ddi_type	Kd	Kd (uM)
ddi	ddi_type	Ki	Ki (uM)
ddi	ddi_type	Km	Km (uM)
toxicity	toxicity_diff_dose_type	complex	Dosing regimen is complex (e.g. several routes of administration are combined)
toxicity	toxicity_diff_dose_type	max	Maximal dose per cohort
toxicity	toxicity_diff_dose_type	mean	Arithmetic mean dose (across time, or across population)
toxicity	toxicity_diff_dose_type	median	Median dose (across time or across population)
toxicity	toxicity_diff_dose_type	mid range	A middle point of a dose range
toxicity	toxicity_diff_dose_type	min	Minimal dose (typically actual dose is larger)
toxicity	toxicity_diff_dose_type	starting	Starting (loading) dose, or initial dose
toxicity	toxicity_diff_dose_type	total	Total dose administered per time period
toxicity	toxicity_diff_dose_type	total daily dose	Total daily dose
toxicity	toxicity_diff_dose_type	total weekly dose	Total weekly dose
toxicity	toxicity_diff_dose_type	total yearly dose	Total yearly dose
toxicity	toxicity_diff_dose_type	typical	Patients from several studies were pooled; typical dose is reported
toxicity	toxicity_diff_dose_type	unknown	The dosage is unknown; there is no other data
toxicity	toxicity_dose_type	Abused dose	Dose which was adminstered by drug abusers
toxicity	toxicity_dose_type	Accidental dose	Dose was administered by accident, by a non-recommended settings (e.g. intravenous drug administered intrathecally)
toxicity	toxicity_dose_type	Higher than recommended	Dose is higher than recommended
toxicity	toxicity_dose_type	Highest recorded dose	Highest dose recorded
toxicity	toxicity_dose_type	Highest studied dose	The dose is highest studied dose at a given route of administration
toxicity	toxicity_dose_type	Lethal dose	Lethal dose
toxicity	toxicity_dose_type	MID	Minimal intolerated dose
toxicity	toxicity_dose_type	Minumum effective dose	Minimum effective dose - the lowest dose level of a pharmaceutical product that provides a clinically significant response in average efficacy, which is also statistically significantly superior to the response provided by the placebo.
toxicity	toxicity_dose_type	MTD	Maximum tolerated dose - the highest dose of a treatment that will produce the desired effect without unacceptable toxicity
toxicity	toxicity_dose_type	Overdose	The dose is reported as 'overdose'
toxicity	toxicity_dose_type	Recommended	Drug is administered at recommended dose level
toxicity	toxicity_dose_type	RP2D	Dose was recommended for Phase 2
toxicity	toxicity_dose_type	Studied dose	The dose was used in the study, without indication about whether the dose is recommended
toxicity	toxicity_dose_type	Toxic dose	Toxic dose
toxicity	toxicity_dose_units	%	Drug concentration in applied formulation (e.g. for topical administration when total mass of administered drug is unknown)
toxicity	toxicity_dose_units	% * h	Total exposure - drug concenration times the duration of administration
toxicity	toxicity_dose_units	% caloric input	Nutrient is administered with food, dose is calculated relative to the total caloric input
toxicity	toxicity_dose_units	drop	Drug volume (typically 50 uL)
toxicity	toxicity_dose_units	g	Drug mass
toxicity	toxicity_dose_units	g/day	Dose rate: drug mass per day
toxicity	toxicity_dose_units	g/kg	Drug mass per kg of body weight
toxicity	toxicity_dose_units	g/kg/day	Dose rate: drug mass per body weight per time period
toxicity	toxicity_dose_units	g/m2	Drug mass per body area
toxicity	toxicity_dose_units	g/m3	Drug concentration
toxicity	toxicity_dose_units	g/mL	Drug concentration in the administered form
toxicity	toxicity_dose_units	MAC	Minimum alveolar concentration
toxicity	toxicity_dose_units	MBq	Quantity of radioactive drug
toxicity	toxicity_dose_units	mg	Drug mass
toxicity	toxicity_dose_units	mg/day	Dose rate: drug mass per day
toxicity	toxicity_dose_units	mg/g aminoacid	Nutrient is administered with food, dose is calculated relative to the mass of aminoacids
toxicity	toxicity_dose_units	mg/h	Dose rate: drug mass per hour
toxicity	toxicity_dose_units	mg/kg	Drug mass per kg of body weight
toxicity	toxicity_dose_units	mg/kg/day	Dose rate: drug mass per body weight per time period
toxicity	toxicity_dose_units	mg/kg/h	Dose rate: drug mass per body weight per time period
toxicity	toxicity_dose_units	mg/m2	Drug mass per body area
toxicity	toxicity_dose_units	mg/m2/day	Dose rate: drug mass per body area per time period
toxicity	toxicity_dose_units	mg/m2/hour	Dose rate: drug mass per body area per time period
toxicity	toxicity_dose_units	mg/m3	Drug concentration
toxicity	toxicity_dose_units	mg/m3/h	Exposure: drug concentration at given environment, per hour of exposure
toxicity	toxicity_dose_units	mg/min	Dose rate: drug mass per min
toxicity	toxicity_dose_units	mg/mL	Drug concentration in the administered form
toxicity	toxicity_dose_units	mL	Drug volume
toxicity	toxicity_dose_units	mL/kg	Drug volume per kg of body weight
toxicity	toxicity_dose_units	mL/kg	Drug volume per kg of body weight
toxicity	toxicity_dose_units	mmol/kg	Drug quantity per kg of body weight
toxicity	toxicity_dose_units	ng/kg/h	Dose rate: drug mass per body weight per time period
toxicity	toxicity_dose_units	ng/kg/min	Dose rate: drug mass per body weight per time period
toxicity	toxicity_dose_units	oz	Drug volume
toxicity	toxicity_dose_units	ppm	Drug concentration at standard level of exposure
toxicity	toxicity_dose_units	ppm/year	Exposure: drug concentration at given environment, per year of exposure
toxicity	toxicity_dose_units	uCi	Quantity of radioactive drug
toxicity	toxicity_dose_units	ug	Drug mass
toxicity	toxicity_dose_units	ug	Drug mass
toxicity	toxicity_dose_units	ug/g	Drug concentration in the administered form
toxicity	toxicity_dose_units	ug/h	Dose rate: drug mass per hour
toxicity	toxicity_dose_units	ug/kg	Drug mass per kg of body weight
toxicity	toxicity_dose_units	ug/kg/day	Dose rate: drug mass per body weight per time period
toxicity	toxicity_dose_units	ug/kg/h	Dose rate: drug mass per body weight per time period
toxicity	toxicity_dose_units	ug/kg/min	Dose rate: drug mass per body weight per time period
toxicity	toxicity_dose_units	ug/m2	Drug mass per body area
toxicity	toxicity_dose_units	ug/mL	Drug concentration in the administered form
toxicity	toxicity_dose_units	uL/kg	Drug volume per kg of body weight
toxicity	toxicity_dose_units	umol/kg	Drug quantity per kg of body weight
toxicity	toxicity_dose_units	unit	Drug quantity (international unit)
toxicity	toxicity_duration_units	course	Duration is provided in drug courses
toxicity	toxicity_duration_units	cycle	Duration is provided in drug treatment cycles. Typical length of a cycle may vary, but usually is around 28 days
toxicity	toxicity_duration_units	day	
toxicity	toxicity_duration_units	episode	Duration is provided as number of episodes when the drug was administered
toxicity	toxicity_duration_units	hour	
toxicity	toxicity_duration_units	min	minute
toxicity	toxicity_duration_units	month	
toxicity	toxicity_duration_units	sec	second
toxicity	toxicity_duration_units	times	Number of times the drug was administered
toxicity	toxicity_duration_units	week	
toxicity	toxicity_duration_units	year	
toxicity	toxicity_experiment_type	multiple	Drug was administered many times, but there is insufficient reason to believe that steady state was reached
toxicity	toxicity_experiment_type	single	Drug was administered once
toxicity	toxicity_experiment_type	steady	Steady-state administration (administration duration exceeds many T1/2 or study explicitly mentions steady state administration)
toxicity	toxicity_frequency_period	10 min	
toxicity	toxicity_frequency_period	15 min	
toxicity	toxicity_frequency_period	2 days	
toxicity	toxicity_frequency_period	2 hours	
toxicity	toxicity_frequency_period	2 months	
toxicity	toxicity_frequency_period	2 weeks	
toxicity	toxicity_frequency_period	2 years	
toxicity	toxicity_frequency_period	24 weeks	
toxicity	toxicity_frequency_period	3 days	
toxicity	toxicity_frequency_period	3 hours	
toxicity	toxicity_frequency_period	3 months	
toxicity	toxicity_frequency_period	3 weeks	
toxicity	toxicity_frequency_period	30 min	
toxicity	toxicity_frequency_period	4 days	
toxicity	toxicity_frequency_period	4 min	
toxicity	toxicity_frequency_period	4 weeks	
toxicity	toxicity_frequency_period	5 min	
toxicity	toxicity_frequency_period	5 weeks	
toxicity	toxicity_frequency_period	6 hours	
toxicity	toxicity_frequency_period	6 weeks	
toxicity	toxicity_frequency_period	60 days	
toxicity	toxicity_frequency_period	60 hours	
toxicity	toxicity_frequency_period	7 weeks	
toxicity	toxicity_frequency_period	70 days	
toxicity	toxicity_frequency_period	8 hours	
toxicity	toxicity_frequency_period	day	
toxicity	toxicity_frequency_period	episode	
toxicity	toxicity_frequency_period	hour	
toxicity	toxicity_frequency_period	month	
toxicity	toxicity_frequency_period	week	
toxicity	toxicity_frequency_period	year	
toxicity	toxicity_health_status	healthy	Drug was investigated on healthy volunteers
toxicity	toxicity_health_status	pregnant	Drug was investigated on pregnant women
toxicity	toxicity_health_status	unhealthy	Drug was investigated on unhealthy patients
toxicity	toxicity_health_status	unknown	Health status of participants is unknown
toxicity	toxicity_routes	caudal epidural	
toxicity	toxicity_routes	dental	
toxicity	toxicity_routes	digestive tract route	
toxicity	toxicity_routes	epidural	
toxicity	toxicity_routes	intraarterial	
toxicity	toxicity_routes	intrabursal	
toxicity	toxicity_routes	intracavernosal	
toxicity	toxicity_routes	intragastric	
toxicity	toxicity_routes	intragluteal	
toxicity	toxicity_routes	intralesional	
toxicity	toxicity_routes	intramuscular	
toxicity	toxicity_routes	intranasal	
toxicity	toxicity_routes	intraocular	
toxicity	toxicity_routes	intraperitoneal	
toxicity	toxicity_routes	intrapleural	
toxicity	toxicity_routes	intrathecal	
toxicity	toxicity_routes	intraurethral	
toxicity	toxicity_routes	intrauterine	
toxicity	toxicity_routes	intravascular	
toxicity	toxicity_routes	intravenous	
toxicity	toxicity_routes	intravesical	
toxicity	toxicity_routes	intravitreal	
toxicity	toxicity_routes	nasogastric	
toxicity	toxicity_routes	ophthalmic	
toxicity	toxicity_routes	oral	
toxicity	toxicity_routes	oral (mother), breasteeding (infant)	Drug was administered orally to breastfeeding mothers; toxicity effects in infants are reported
toxicity	toxicity_routes	oromucosal	Oral rinsing, tooth brushing etc
toxicity	toxicity_routes	otic	
toxicity	toxicity_routes	parenteral	
toxicity	toxicity_routes	rectal	
toxicity	toxicity_routes	respiratory	
toxicity	toxicity_routes	subcutaneous	
toxicity	toxicity_routes	subdermal	
toxicity	toxicity_routes	subgingival	
toxicity	toxicity_routes	sublingual	
toxicity	toxicity_routes	submucosal	
toxicity	toxicity_routes	supraperiosteal injection	
toxicity	toxicity_routes	topical	
toxicity	toxicity_routes	transdermal	
toxicity	toxicity_routes	vaginal	
toxicity	toxicity_sex	F	Only female patients were investigated
toxicity	toxicity_sex	M	Only male patients were investigated
toxicity	toxicity_sex	M+F	Both male and female patients were investigated
toxicity	toxicity_sex	unknown	Sex is unknown
toxicity	toxicity_species	Homo sapiens	
pk	pk_age_group	ADOLESCENT	Adolescents
pk	pk_age_group	ADULT	Adults
pk	pk_age_group	CHILD	Children
pk	pk_age_group	NEWBORN	Newborn children
pk	pk_age_group	UNKNOWN	Age is unknown
pk	pk_analyte_tissue	AQUEOUS HUMOR	
pk	pk_analyte_tissue	BLOOD	
pk	pk_analyte_tissue	BRAIN	
pk	pk_analyte_tissue	CEREBROSPINAL FLUID	
pk	pk_analyte_tissue	CORNEA	
pk	pk_analyte_tissue	INFLAMMATORY EXUDATE	
pk	pk_analyte_tissue	MUSCLE	
pk	pk_analyte_tissue	NAIL	
pk	pk_analyte_tissue	PLASMA	
pk	pk_analyte_tissue	RED BLOOD CELLS	
pk	pk_analyte_tissue	SALIVA	
pk	pk_analyte_tissue	SERUM	
pk	pk_analyte_tissue	SKIN	
pk	pk_analyte_tissue	SPUTUM	
pk	pk_analyte_tissue	STRIATUM	
pk	pk_analyte_tissue	TUMOR	
pk	pk_analyte_tissue	UNKNOWN	
pk	pk_analyte_tissue	URINE	
pk	pk_analyte_tissue	VAGINAL FLUID	
pk	pk_auc_type	?	The time limit for AUC is unknown
pk	pk_auc_type	∞	AUC0-∞ (from t=0 to t=∞)
pk	pk_auc_type	t	AUC0-t (the specific value of t, in hours, is provided in pk_auc_hours)
pk	pk_auc_units	g × h/L	Concentration [analyte mass / tissue volume] × time
pk	pk_auc_units	g × h/mL	Concentration [analyte mass / tissue volume] × time
pk	pk_auc_units	M × min	Concentration [analyte quantity / tissue volume] × time
pk	pk_auc_units	mg × day/L	Concentration [analyte mass / tissue volume] × time
pk	pk_auc_units	mg × h/dL	Concentration [analyte mass / tissue volume] × time
pk	pk_auc_units	mg × h/g	Concentration [analyte mass / tissue mass] × time
pk	pk_auc_units	mg × h/kg	Concentration [analyte mass / tissue mass] × time
pk	pk_auc_units	mg × h/L	Concentration [analyte mass / tissue volume] × time
pk	pk_auc_units	mg × h/L per 1.73 m²	Concentration [analyte mass / tissue volume] × time per body area
pk	pk_auc_units	mg × h/L/(mg dose/kg)	Concentration [analyte mass / tissue volume] × time per dose of administered drug per body mass
pk	pk_auc_units	mg × h/mL	Concentration [analyte mass / tissue volume] × time
pk	pk_auc_units	mg × h/mL/(mg dose/kg)	Concentration [analyte mass / tissue volume] × time per dose of administered drug per body mass
pk	pk_auc_units	mg × min/L	Concentration [analyte mass / tissue volume] × time
pk	pk_auc_units	mg × min/mL	Concentration [analyte mass / tissue volume] × time
pk	pk_auc_units	mM × h	Concentration [analyte quantity / tissue volume] × time
pk	pk_auc_units	mM × min	Concentration [analyte quantity / tissue volume] × time
pk	pk_auc_units	ng × day/mL	Concentration [analyte mass / tissue volume] × time
pk	pk_auc_units	ng × eq × h/g	Concentration [analyte mass-equivalents / tissue mass] × time
pk	pk_auc_units	ng × eq × h/mL	Concentration [analyte mass-equivalents / tissue volume] × time
pk	pk_auc_units	ng × h/dL	Concentration [analyte mass / tissue volume] × time
pk	pk_auc_units	ng × h/g	Concentration [analyte mass / tissue mass] × time
pk	pk_auc_units	ng × h/L	Concentration [analyte mass / tissue volume] × time
pk	pk_auc_units	ng × h/mL	Concentration [analyte mass / tissue volume] × time
pk	pk_auc_units	ng × h/mL/kg	Concentration [analyte mass / tissue volume] × time per body mass
pk	pk_auc_units	ng × h/mL/m²	Concentration [analyte mass / tissue volume] × time per body area
pk	pk_auc_units	ng × min/L	Concentration [analyte mass / tissue volume] × time
pk	pk_auc_units	ng × min/mL	Concentration [analyte mass / tissue volume] × time
pk	pk_auc_units	ng × week/mg	Concentration [analyte mass / tissue mass] × time
pk	pk_auc_units	ng × week/mL	Concentration [analyte mass / tissue volume] × time
pk	pk_auc_units	nM × day	Concentration [analyte quantity / tissue volume] × time
pk	pk_auc_units	nM × h	Concentration [analyte quantity / tissue volume] × time
pk	pk_auc_units	nM × h/kg	Concentration [analyte quantity / tissue volume] × time per body mass
pk	pk_auc_units	nM × min	Concentration [analyte quantity / tissue volume] × time
pk	pk_auc_units	nmol × h/mL	Concentration [analyte quantity / tissue volume] × time
pk	pk_auc_units	pg × h/mL	Concentration [analyte mass / tissue volume] × time
pk	pk_auc_units	pg × min/mL	Concentration [analyte mass / tissue volume] × time
pk	pk_auc_units	pmol × h/g	Concentration [analyte quantity / tissue mass] × time
pk	pk_auc_units	pmol × h/mL	Concentration [analyte quantity / tissue volume] × time
pk	pk_auc_units	μg × day/mL	Concentration [analyte mass / tissue volume] × time
pk	pk_auc_units	μg × eq × h/g	Concentration [analyte mass-equivalents / tissue mass] × time
pk	pk_auc_units	μg × eq × h/mL	Concentration [analyte mass-equivalents / tissue volume] × time
pk	pk_auc_units	μg × h/g	Concentration [analyte mass / tissue volume] × time
pk	pk_auc_units	μg × h/L	Concentration [analyte mass / tissue volume] × time
pk	pk_auc_units	μg × h/L/(mg dose)	Concentration [analyte mass / tissue volume] × time per mass of administered drug
pk	pk_auc_units	μg × h/mL	Concentration [analyte mass / tissue volume] × time
pk	pk_auc_units	μg × h/mL/m²	Concentration [analyte mass / tissue volume] × time per body area
pk	pk_auc_units	μg × min/g	Concentration [analyte mass / tissue mass] × time
pk	pk_auc_units	μg × min/L	Concentration [analyte mass / tissue volume] × time
pk	pk_auc_units	μg × min/mL	Concentration [analyte mass / tissue volume] × time
pk	pk_auc_units	μM × h	Concentration [analyte quantity / tissue volume] × time
pk	pk_auc_units	μM × h/mL × kg	Total exposure ?
pk	pk_auc_units	μM × min	Concentration [analyte quantity / tissue volume] × time
pk	pk_cmax_units	g/mL	Concentration [analyte mass / tissue volume]
pk	pk_cmax_units	mg/dL	Concentration [analyte mass / tissue volume]
pk	pk_cmax_units	mg/g	Concentration [analyte mass / tissue mass]
pk	pk_cmax_units	mg/kg	Concentration [analyte mass / tissue mass]
pk	pk_cmax_units	mg/L	Concentration [analyte mass / tissue volume]
pk	pk_cmax_units	mg/mL	Concentration [analyte mass / tissue volume]
pk	pk_cmax_units	mM	Concentration [analyte quantity / tissue volume]
pk	pk_cmax_units	ng × eq/g	Concentration [analyte mass-equivalents / tissue mass]
pk	pk_cmax_units	ng × eq/mL	Concentration [analyte mass-equivalents / tissue volume]
pk	pk_cmax_units	ng/dL	Concentration [analyte mass / tissue volume]
pk	pk_cmax_units	ng/g	Concentration [analyte mass / tissue mass]
pk	pk_cmax_units	ng/L	Concentration [analyte mass / tissue volume]
pk	pk_cmax_units	ng/mL	Concentration [analyte mass / tissue volume]
pk	pk_cmax_units	ng/mL/kg	Concentration [analyte mass / tissue volume] per body mass
pk	pk_cmax_units	nM	Concentration [analyte quantity / tissue volume]
pk	pk_cmax_units	nmol/mL	Concentration [analyte quantity / tissue volume]
pk	pk_cmax_units	pg/mL	Concentration [analyte mass / tissue volume]
pk	pk_cmax_units	pmol/g	Concentration [analyte quantity / tissue mass]
pk	pk_cmax_units	pmol/mL	Concentration [analyte quantity / tissue volume]
pk	pk_cmax_units	unit/mL	Concentration [analyte unit / tissue volume]
pk	pk_cmax_units	μg × eq/g	Concentration [analyte mass-equivalents / tissue mass]
pk	pk_cmax_units	μg/g	Concentration [analyte mass / tissue mass]
pk	pk_cmax_units	μg/L	Concentration [analyte mass / tissue volume]
pk	pk_cmax_units	μg/mL	Concentration [analyte mass / tissue volume]
pk	pk_cmax_units	μM	Concentration [analyte quantity / tissue volume]
pk	pk_dose_type	DEFINED DAILY	The assumed average maintenance dose per day for a drug used for its main indication in adults.
pk	pk_dose_type	INVESTIGATIONAL	Investigational dose (used when no other information is available)
pk	pk_dose_type	MAX DAILY	Maximal recommended daily dose
pk	pk_dose_type	MAX TOLERATED	Maximum tolerated dose - the highest dose of a treatment that will produce the desired effect without unacceptable toxicity.
pk	pk_dose_type	MIN EFFICACIOUS	Minimum effective dose - the lowest dose level of a pharmaceutical product that provides a clinically significant response in average efficacy, which is also statistically significantly superior to the response provided by the placebo.
pk	pk_dose_type	NOAEL	No Observed Adverse Effect Level - An exposure level at which there are no statistically or biologically significant increases in the frequency or severity of adverse effects between the exposed population and its appropriate control; some effects may be produced at this level, but they are not considered as adverse, or as precursors to adverse effects.
pk	pk_dose_type	RECOMMENDED	Recommended dose
pk	pk_dose_type	UNKNOWN	Dose type is unknown
pk	pk_dose_units	%	Drug concentration in applied formulation (e.g. for topical administration when total mass of administered drug is unknown)
pk	pk_dose_units	drop	Drug volume (typically 50 uL)
pk	pk_dose_units	g	Drug mass
pk	pk_dose_units	g/kg	Drug mass per kg of the body weight
pk	pk_dose_units	g/m²	Drug mass per square meter of body area
pk	pk_dose_units	MBq	Quantity of administered radioactive material
pk	pk_dose_units	mg	Drug mass
pk	pk_dose_units	mg × eq	Drug mass
pk	pk_dose_units	mg/cm²	Drug mass per area onto which the drug was applied
pk	pk_dose_units	mg/h	Dose rate: drug mass administered per hour
pk	pk_dose_units	mg/kg	Drug mass per kg of the body weight
pk	pk_dose_units	mg/kg bw	Drug mass per kg of the body weight
pk	pk_dose_units	mg/kg m.a.m.	Drug mass per kg of metabolically active body mass (MAM= weight to the power of 0.7)
pk	pk_dose_units	mg/kg/h	Dose rate: drug mass administered per hour per kg of body mass
pk	pk_dose_units	mg/m²	Drug mass per square meter of body area
pk	pk_dose_units	mL	Drug volume
pk	pk_dose_units	mL/kg	Drug volume per kg of the body weight
pk	pk_dose_units	mmol	Drug quantity
pk	pk_dose_units	mmol/h	Dose rate: drug quantity administered per hour
pk	pk_dose_units	mmol/kg	Drug quantity per kg of the body weight
pk	pk_dose_units	mmol/m²	Drug quantity per square meter of body area
pk	pk_dose_units	ng/cm²	Dose per square cm of the affected area
pk	pk_dose_units	ng/kg/min	Dose rate: drug mass administered per hour per kg of body mass
pk	pk_dose_units	ng/m²	Drug mass per square meter of body area
pk	pk_dose_units	nmol	Drug quantity
pk	pk_dose_units	nmol/kg	Drug quantity per kg of the body weight
pk	pk_dose_units	unit	Drug quantity (international units)
pk	pk_dose_units	μg	Drug mass
pk	pk_dose_units	μg/cm²	Drug mass per area onto which the drug was applied
pk	pk_dose_units	μg/kg	Drug mass per kg of the body weight
pk	pk_dose_units	μg/kg bw	Drug mass per kg of the body weight
pk	pk_dose_units	μg/kg/h	Dose rate: drug mass administered per hour per kg of body mass
pk	pk_dose_units	μg/kg/min	Dose rate: drug mass administered per min per kg of body mass
pk	pk_dose_units	μg/m²	Drug mass per square meter of body area
pk	pk_dose_units	μL	Drug volume
pk	pk_dose_units	μL/cm²	Drug volume per area onto which the drug was applied
pk	pk_dose_units	μmol	Drug quantity
pk	pk_dose_units	μmol/kg	Drug quantity per kg of the body weight
pk	pk_dose_units	μmol/kg/min	Dose rate: drug quantity administered per min per kg of body mass
pk	pk_experiment_type	MULTIPLE	PK was measured after a drug was administered multiple times (but not at steady state, or relation to a steady state is unknown)
pk	pk_experiment_type	OTHER	Other administration type was applied (see pk_exp_other_types for additional information)
pk	pk_experiment_type	SINGLE	PK was measured after a single drug administration
pk	pk_experiment_type	STEADY-STATE	PK was measured at steady state
pk	pk_experiment_type	UNKNOWN	Experiment type is unknown or not applicable
pk	pk_food_status	FASTED	Drug was administered to fasting patients
pk	pk_food_status	FED	Drug was administered to fed patients
pk	pk_food_status	HIGH-FAT	Drug was administered to patients after a high-fat meal
pk	pk_food_status	LOW-FAT	Drug was administered to patients after a low-fat meal
pk	pk_food_status	UNKNOWN	Food status is unknown
pk	pk_frequency_period	2 days	
pk	pk_frequency_period	2 hours	
pk	pk_frequency_period	2 weeks	
pk	pk_frequency_period	3 days	
pk	pk_frequency_period	3 hours	
pk	pk_frequency_period	3 weeks	
pk	pk_frequency_period	4 days	
pk	pk_frequency_period	4 weeks	
pk	pk_frequency_period	5 days	
pk	pk_frequency_period	5 weeks	
pk	pk_frequency_period	day	
pk	pk_frequency_period	hour	
pk	pk_frequency_period	min	
pk	pk_frequency_period	UNKNOWN	
pk	pk_frequency_period	week	
pk	pk_health_status	HEALTHY	Study participants are healthy
pk	pk_health_status	PREGNANT	Study participants are pregnant women
pk	pk_health_status	UNHEALTHY	Study participants are unhealthy
pk	pk_health_status	UNKNOWN	Health status of study participants is unknown
pk	pk_routes	Auricular (otic)	
pk	pk_routes	Brachial plexus block	
pk	pk_routes	Buccal	
pk	pk_routes	Caudal	
pk	pk_routes	Dental	
pk	pk_routes	Endotracheal	
pk	pk_routes	Enteral	
pk	pk_routes	Epidural	
pk	pk_routes	Intra-arterial	
pk	pk_routes	Intraarticular	
pk	pk_routes	Intracavitary	
pk	pk_routes	Intracerebral	
pk	pk_routes	Intracoronary	
pk	pk_routes	Intragastric	
pk	pk_routes	Intralesional	
pk	pk_routes	Intralymphatic	
pk	pk_routes	Intramuscular	
pk	pk_routes	Intraocular	
pk	pk_routes	Intraoral Submucosal Injection	
pk	pk_routes	Intraperitoneal	
pk	pk_routes	Intrapleural	
pk	pk_routes	Intraspinal	
pk	pk_routes	Intrathecal	
pk	pk_routes	Intravascular	
pk	pk_routes	Intravenous	
pk	pk_routes	Intraventricular	
pk	pk_routes	Intravesical	
pk	pk_routes	Irrigation	
pk	pk_routes	Lumbar injection	
pk	pk_routes	Nasal	
pk	pk_routes	Nasogastric	
pk	pk_routes	Ocular	
pk	pk_routes	Oral	
pk	pk_routes	Oral transmucosal	
pk	pk_routes	OTHER	
pk	pk_routes	Parenteral	
pk	pk_routes	Peridural	
pk	pk_routes	Rectal	
pk	pk_routes	Respiratory	
pk	pk_routes	Subcutaneous	
pk	pk_routes	Subcutaneous implant	
pk	pk_routes	Sublingual	
pk	pk_routes	Topical	
pk	pk_routes	Transdermal	
pk	pk_routes	UNKNOWN	
pk	pk_routes	Vaginal	
pk	pk_sex	FEMALE	Female only
pk	pk_sex	FEMALE / MALE	Male and female
pk	pk_sex	MALE	Male only
pk	pk_sex	UNKNOWN	Sex is unknown
pk	pk_source_type	DRUG LABEL	FDA drug label
pk	pk_source_type	EXPERIMENT	Experimental articles
pk	pk_source_type	OTHER	Other sources
pk	pk_source_type	OTHER GOV'T	Other government document (FDA reviews, foreign regulatory documents)
pk	pk_source_type	PATENT	Patents
pk	pk_source_type	REVIEW	Review articles
pk	pk_species	Bos taurus	Bovine
pk	pk_species	Canis lupus	Dog
pk	pk_species	Capra hircus	Goat
pk	pk_species	Equus caballus	Horse
pk	pk_species	Gallus gallus domesticus	Chicken
pk	pk_species	Homo sapiens	
pk	pk_species	Macaca fascicularis	Crab-eating macaque (cynomolgus monkey)
pk	pk_species	Macaca mulatta	Rhesus macaque
pk	pk_species	Mesocricetus auratus	Golden hamster
pk	pk_species	Mus musculus	Mouse
pk	pk_species	Oncorhynchus mykiss	Rainbow trout
pk	pk_species	Oryctolagus cuniculus	Rabbit
pk	pk_species	Ovis aries	Sheep
pk	pk_species	Papio anubis	Olive baboon
pk	pk_species	Rattus norvegicus	Rat
pk	pk_species	Salmo salar	Atlantic salmon
pk	pk_species	Sus scrofa	Pig
pk	pk_thalf_units	day	
pk	pk_thalf_units	h	
pk	pk_thalf_units	min	
pk	pk_thalf_units	s	
pk	pk_dose_type	HIGHEST STUDIED	Highest studied dose for a given route of administration
pk	pk_dose_type	RP2D	Dose recommended for phase 2 trials
pk	pk_source_type	NCT	ClinicalTrials.gov
